Rare Disease Trial, Recruiting NCT06871696 Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT06871696
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who wish to take part voluntarily
  • Parents (mothers or fathers) of a child with an intellectual disability and/or autism spectrum disorder where the genetic cause is known — this includes conditions caused by a single gene change or by missing or extra sections of genetic material (called copy number variations)
  • Adults who themselves have an intellectual disability and/or autism spectrum disorder of known genetic cause, if they wish to take part and are able to do so
  • People who are aware of the specific genetic cause behind their family member's intellectual disability or autism spectrum disorder — in some cases, people whose family member has a recognised syndrome being investigated for a genetic cause may also be considered eligible, subject to approval by the trial's scientific committee
  • People who have the ability and means to complete an online questionnaire
  • People who have read the study information sheet and agreed to the general conditions of participation
  • There are no restrictions based on age, gender, or other health conditions of the person joining the trial

Who may not be able to join:

  • Parents or individuals where the intellectual disability and/or autism spectrum disorder has no identified genetic cause — unless the exception described above (involving a recognised syndrome under review) is approved by the trial's scientific committee
  • People under the age of 18 are not permitted to enter data directly, though a parent may enter information about their minor child as part of their own participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03 88 65 32 10

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Registry
ClinicalTrials.gov
Start date
1 November 2016
Est. completion
1 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Description of the clinical and "para-clinical" characteristics of the disease over time in adult and pediatric patients, depending on the type of genetic anomaly associated with the disease.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov